Rapid Bacterial Tests: ASU Scientists Unveil Breakthrough to Determine Antibiotic Efficacy
Bacteria can double their numbers in under four minutes. This rapid multiplication raises a vital question for doctors treating infections: Will the chosen antibiotic be effective?
Shaopeng Wang, an associate professor of biomedical engineering at Arizona State University, has developed a new method that quickly identifies bacterial infections and tests antibiotic effectiveness. He recently received a patent for his technique which analyzes urine samples using video-based object scattering detection. This method offers quicker and more precise results than traditional testing, with hopes to implement it in doctors’ offices globally.
Antibiotics kill bacteria by targeting essential components like cell walls or DNA. However, some bacteria develop resistance, surviving treatment and reproducing. This resistance often increases with repeated antibiotic use. To combat this issue, antibiotic susceptibility tests are crucial in clinical labs. Unfortunately, conventional methods, like culturing bacteria, can take up to three days, leaving doctors to guess which broad-spectrum antibiotic to prescribe in the meantime. This guessing game not only delays effective treatment but also fuels antibiotic resistance. In some cases, antibiotics may not be suitable, such as for viral infections.
Wang’s innovative method eliminates the lengthy culture step. His technique uses a scattering image to measure light intensity changes as bacteria grow. “As bacteria grow, the scattered light becomes brighter, allowing us to track changes without needing any labels,” Wang explains.
Focusing on urinary tract infections (UTIs), which predominantly affect women, Wang and his team have significantly improved detection times. They can identify infections in just 30 minutes and determine antibiotic susceptibility in 90 minutes, achieving 98% accuracy compared to the traditional three-day standard.
How does Dr. Wang’s technique compare to traditional methods in terms of speed and accuracy of diagnosing bacterial infections?
News Directory 3 Interview: Revolutionizing Antibiotic Treatment with Dr. Shaopeng Wang
In a groundbreaking development in the fight against bacterial infections, Dr. Shaopeng Wang, an associate professor of biomedical engineering at Arizona State University, has devised a method that could potentially reshape how we diagnose and treat these ailments. With a newly patented technique that utilizes video-based object scattering detection to analyze urine samples, Dr. Wang aims to expedite the identification of bacterial infections and the effectiveness of prescribed antibiotics. We sat down with Dr. Wang to discuss the implications of his work.
News Directory 3 (ND3): Thank you for joining us today, Dr. Wang. Your new method for identifying bacterial infections sounds promising. Can you explain how your technique works and what sets it apart from traditional methods?
Dr. Shaopeng Wang (SW): Thank you for having me. My method leverages video-based object scattering detection to analyze urine samples for the presence of bacteria. The key advantage here is speed and precision. Traditional methods, such as culturing bacteria, can take two to three days, which delays treatment. In contrast, my technique can deliver results in under an hour. This rapid turnaround is critical for effective treatment, especially in cases where time-sensitive decisions are crucial.
ND3: In light of recent concerns regarding antibiotic resistance, how does your approach address the issue of antibiotic susceptibility?
SW: Antibiotic resistance is a growing challenge in medicine. When prescribing antibiotics, doctors often have to make educated guesses based on broad-spectrum treatments, which may not be effective against the specific bacteria causing the infection. My method not only identifies the type of bacteria present but also tests for antibiotic susceptibility quickly. This allows healthcare providers to prescribe the most effective treatment right away, reducing the risk of resistance development and improving patient outcomes.
ND3: You mentioned that some bacteria can double in number in under four minutes. How does this rapid multiplication complicate the treatment process?
SW: Exactly. Bacteria can replicate incredibly fast, which means an infection can worsen rapidly if not treated appropriately. Knowing which antibiotic will work before the bacteria multiply further is essential for effective treatment. This urgency is what my technique aims to address—it provides timely information to help clinicians make informed decisions, ultimately leading to better patient care.
ND3: Looking ahead, what are your plans for implementing this technology in clinical settings?
SW: We’re actively looking to partner with healthcare institutions and laboratories to refine and validate this method. My hope is to roll it out in doctors’ offices worldwide, allowing for immediate testing as part of patient consultations. This way, patients can receive tailored treatments promptly, improving recovery rates and minimizing complications.
ND3: What challenges do you foresee in bringing this innovative technique to the healthcare market?
SW: One of the main challenges is regulatory approval. Any new diagnostic method must meet stringent standards for safety and efficacy. Additionally, educating healthcare professionals about the technology and its benefits will be crucial for adoption. However, I believe that the potential for improved patient outcomes will drive interest and encourage the integration of this method into clinical practice.
ND3: Thank you, Dr. Wang, for sharing insights into your revolutionary work. It’s exciting to see such advancements that could significantly impact antibiotic treatment and resistance.
SW: Thank you for the conversation. I’m optimistic about the future of bacterial infection treatment and hopeful that my method can contribute to combating the increasing issue of antibiotic resistance.
As the fight against bacterial infections continues, innovations like Dr. Wang’s method may provide the key to quicker diagnoses and more effective treatments, helping to safeguard public health in an era of rising antibiotic resistance.
Postdoctoral researcher Jiapei Jiang highlights the urgency of precise diagnoses, especially for life-threatening conditions like sepsis. Current testing delays lead to excessive antibiotic use, disrupting the patient’s microbiome. Wang’s method enables detection at the bacterial level, tracking E. coli growth, which can double every 20 minutes.
Using a low-zoom microscope, the team can observe larger sample volumes. Their scattering imaging technique measures light intensity changes, eliminating the need for complicating labels.
This new approach aims to provide timely and accurate diagnostics, allowing clinicians to prescribe the right antibiotics immediately. The potential benefits include not only more effective treatments but also a reduction in antibiotic misuse, a key factor in rising drug resistance.
Wang and his team want to make this technology widely accessible, transforming the management of bacterial infections. Faster, accurate diagnostics could mark a significant advancement in medical care, improving patient outcomes while addressing antibiotic resistance.
